Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD).

“We find that a lot of young people don’t pass the [fertility] test because you have to have an anti-mullerian hormone (AMH) level of about three and over nanograms per millilitre to be able to ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK ® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of people with cystic ...

Initiation follows successful IND clearance based on preclinical data package indicating robust increase in fetal hemoglobin with no cytotoxicity ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

The World Health Organization has released its first-ever global guideline on the management of sickle cell disease during ...

A doctor says she’s scrambling to figure out how she’ll continue her work helping sickle cell disease patients after the ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...

Considering a change to your treatment regimen? Columnist Mary Shaniqua shares tips to help patients and providers make an ...

Sickle cell disease (SCD) is a condition that directly affects the way the red blood cells of the body carry oxygen. This can lead to further complications. In an interview with HT Lifestyle, Dr Vikas ...